A thrombophilia family with protein S deficiency due to protein translation disorders caused by a Leu607Ser heterozygous mutation in PROS1

Abstract

Background Protein S deficiency (PSD) is an autosomal dominant hereditary disease. In 1984, familial PSD was reported to be prone to recurrent thrombosis. Follow-up studies have shown that heterozygous protein S (PROS1) mutations increase the risk of thrombosis. More than 300 PROS1 mutations have been identified; among them, only a small number of mutations have been reported its possible mechanism to reduce plasma protein S (PS) levels. However, whether PROS1 mutations affect protein structure and why it can induce PSD remains unknown. Methods The clinical phenotypes of the members of a family with thrombosis were collected. Their PS activity was measured using the coagulation method, whereas their protein C and antithrombin III activities were measured using methods such as the chromogenic substrate method. The proband and her parents were screened for the responsible mutation using second-generation whole exon sequencing, and the members of the family were verified for suspected mutations using Sanger sequencing. Mutant and wild type plasmids were constructed and transfected into HEK293T cells to detect the mRNA and protein expression of PROS1. Results In this family, the proband with venous thrombosis of both lower extremities, the proband’s mother with pulmonary embolism and venous thrombosis of both lower extremities, and the proband’s younger brother had significantly lower PS activity and carried a PROS1 c. 1820 T > C:p.Leu607Ser heterozygous mutation (NM_000313.3). However, no such mutations were found in family members with normal PS activity. The PS expression in the cell lysate and supernatant of the Leu607Ser mutant cells decreased, while mRNA expression increased. Immunofluorescence localization showed that there was no significant difference in protein localization before and after mutation. Conclusions The analysis of family phenotype, gene association, and cell function tests suggest that the PROS1 Leu607Ser heterozygous mutation may be a pathogenic mutation. Serine substitution causes structural instability of the entire protein. These data indicate that impaired PS translation and synthesis or possible secretion impairment is the main pathogenesis of this family with hereditary PSD and thrombophilia.

Levels of Protein S in Saudi Patients with Myocardial Infarction

“…Hereditary thrombophilia (also known as hypercoagulability) is an inherited increased proclivity for intravascular thrombi (either venous or arterial), which primarily affects young people (under 45 years old) and is recurrent. A considerable percentage of those affected have a noticeable anomaly, but the majority develop thrombosis only when other risk factors are present [12,13]. MI is a common occurrence in adults but not in younger populations.…”

A clinical analysis of intestinal mucosal necrosis and exfoliation induced by superior mesenteric vein thrombosis: A case report

“…The patient had recurrent thrombosis, but the specific etiology was unclear, which may be related to genetic factors. For example, mutations in PROS1 lead to protein S deficiency, and MTHFR or Factor V Leiden mutations can lead to hereditary thrombosis ( 18 ). Acquired viral infections or drug factors can also cause thrombosis.…”

Retrospective Analysis of the Effect of Lidocaine Combined with Methylprednisolone on Pain Control After Uterine Artery Embolization

“…Opioids may cause adverse reactions such as nausea and vomiting, with increased severity of adverse reactions directly related to the amount of opioids used ( 29 ). However, differences in the amounts of drugs administered to patients are related to individual clinical characteristics, surgery duration, and tumor type and size ( 30 ). Consequently, it is necessary to reduce the amount of sufentanil administered as much as possible to avoid the occurrence of related adverse reactions.…”